First human trial of NIH-GSK Ebola vaccine shows promise

Lisa Schnirring | Staff Writer | CIDRAP NewsNov 26, 2014Study results showed a good immune response at a high dose.Share Tweet LinkedIn Email Print & PDF
Nov 26, 2014

Study results showed a good immune response at a high dose.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest